Compare AESPR & SLBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
| Metric | AESPR | SLBT |
|---|---|---|
| Founded | N/A | N/A |
| Country | United States | Taiwan |
| Employees | N/A | 20 |
| Industry | Blank Checks | |
| Sector | Finance | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | N/A | 2.4B |
| IPO Year | 2026 | N/A |
| Metric | AESPR | SLBT |
|---|---|---|
| Price | $0.19 | $2.80 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 171.9K | ★ 204.9K |
| Earning Date | N/A | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.16 | $2.80 |
| 52 Week High | $0.20 | $6.25 |
| Indicator | AESPR | SLBT |
|---|---|---|
| Relative Strength Index (RSI) | 50.00 | 34.91 |
| Support Level | $0.17 | N/A |
| Resistance Level | N/A | $4.91 |
| Average True Range (ATR) | 0.01 | 0.42 |
| MACD | 0.00 | -0.18 |
| Stochastic Oscillator | 75.00 | 3.99 |
SL Science Holding Ltd is a biomedical company specialized in developing cellular and gene therapies advancing regenerative medicine and cancer treatment. It utilizes immune stem cells to target cancer and bovine-derived milk exosomes to regenerate damaged tissues, thus potentially offering expansive medical applications for its products. With proprietary technologies such as Armed-T and Gamma Delta T cells, as well as exosome applications in skincare and cancer recovery. It operates in three segments namely Exosome products, CD-19 Armed-T products, and GDT cell therapy products. It derives revenue from Exosome products segment.